← Open Payments lookup

PETER KOWALSKI: Open Payments

NPI 1639107444 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$272 in 14 payments from 7 companies in 2025. Trend: 2023 $1,754 · 2024 $1,810 · 2025 $272

Food & beverage: $272
CompanyPaymentsAmount
Alkermes, Inc.4$78
E.R. Squibb & Sons, L.L.C.3$62
Lundbeck LLC3$58
Neurocrine BioSciences, Inc.1$27
Otsuka America Pharmaceutical, Inc.1$18
Teva Pharmaceuticals USA, Inc.1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: ARISTADA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA.

Industry payments across AZ — which companies pay providers there.